Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1110)
  2. Meeting Abstract (903)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (37)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2188)
  2. Department of Medicine (2182)
  3. Gynecology Disease Management Team (1882)
  4. GDMT, Medicine (1864)
  5. Surgery (604)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (616)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (275)
  5. Vicky Makker (270)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (83)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (459)
  2. Gynecologic Oncology (421)
  3. International Journal of Gynecological Cancer (162)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (500)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (189)
  4. American Association for Cancer Research (174)
  5. Oxford University Press (145)
  6. Elsevier Inc. (129)

More Publishers

Results (2188)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: A phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer
    Journal Article

    Grisham, R.; Monk, B. J.; Van Nieuwenhuysen, E.; Moore, K. N.; Fabbro, M.; O'Malley, D. M.; Oaknin, A.; Thaker, P.; Oza, A. M.; Colombo, N.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Health disparities among women who received treatment for 1L advanced and recurrent endometrial cancer in the United States
    Meeting Abstract

    McClain, K. M.; Prabhu, V. S.; Marupuru, S.; Meng, K.; Tran, V.; Woodhouse, K.; Meng, R.; Green, A. K.; Makker, V.
    Cancer Epidemiology Biomarkers and Prevention (2025)

    Fulltext@MSK | Save
  • PYNNACLE phase II clinical trial protocol: Rezatapopt (PC14586) monotherapy in advanced or metastatic solid tumors with a TP53 Y220C mutation
    Journal Article

    Schram, A. M.; Fellous, M.; LeDuke, K.; Schmid, A.; Dumbrava, E. E.
    Future Oncology (2025)

    Fulltext@MSK | Save
  • A phase I study of AZD8186 in combination with docetaxel in patients with PTEN-mutated or PIK3CB-mutated advanced solid tumors
    Journal Article

    Schram, A. M.; Takebe, N.; Chen, A.; Zhou, Q.; Iasonos, A.; Silber, J.; Reynolds, M.; Hussain, S.; Gavriliuc, M.; Smyth, L. M.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Embracing and implementing the WHO cervical cancer elimination campaign goals: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS on minimum quality care standards for cervical cancer patients in the U.S
    Editorial

    Zhou, N. Y.; Beavis, A. L.; Lin, L. L.; Neibart, S. S.; Chino, J.; Pierce, J. Y.; O'Cearbhaill, R. E.; Dewdney, S. B.; Farid, H.; Chen, L. M.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Clinical utility and prognostic implications of circulating cell-free DNA in biliary tract cancer
    Journal Article

    Cowzer, D.; Darmofal, M.; Seier, K.; Thummalapalli, R.; Walch, H.; El Dika, I.; Khalil, D. N.; Park, W.; Dhyani, A.; Yaqubie, A.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Primary analysis of EPIK-O/ENGOT-ov61: Alpelisib plus olaparib versus chemotherapy in platinum-resistant or platinum-refractory high-grade serous ovarian cancer without BRCA mutation
    Journal Article

    Konstantinopoulos, P. A.; Kim, J. W.; Freyer, G.; Lee, J. Y.; Gaba, L.; Grisham, R. N.; Colombo, N.; Wu, X.; Sehouli, J.; Cruz, F.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: A retrospective case series
    Journal Article

    Nykaza, I.; Moy, A.; Dusza, S. W.; Moskowitz, A.; Iyer, G.; Iqbal, A.; Motzer, R.; Ilson, D. H.; O'Cearbhaill, R. E.; Kazi, R.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • A first-in-human phase 1 study Of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors (trial in progress)
    Meeting Abstract

    Ray-Coquard, I. L.; O'Malley, D. M.; Oaknin, A.; Pothuri, B.; Lorusso, D.; Eskander, R. N.; Westin, S. N.; Lakhani, N.; McKean, W. B.; Koyama, T.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • An open-label, multicentre, phase 2 study of trastuzumab deruxtecan in patients with HER2-expressing solid tumours: DESTINY-PanTumor02 Part 2
    Meeting Abstract

    Oaknin, A.; Lee, J. Y.; Makker, V.; Oh, D. Y.; Anoka, C.; Jung, L.; Puvvada, S.; Simões, J.; Meric-Bernstam, F.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save